Complementary body weight and cardiometabolic benefits of higher GLP-1 and lower GIP: genetic evidence from large-scale phenomic analyses

孟德尔随机化 医学 疾病 肥胖 内分泌学 内科学 生理学 生物 生命银行 生物信息学 2型糖尿病 代谢综合征 动脉粥样硬化性心血管疾病 二肽基肽酶-4 体重 空腹血糖值 调解 多效性 遗传关联 脂肪变性 遗传学 表型 冠心病
作者
Lijuan Wang,Fangyuan Jiang,Shuai Yuan,Jing Sun,Jianhui Zhao,Siyun Zhou,Jingyi Liang,Haiqing Li,Peige Song,Shengfeng Wang,Jianzeng Dong,Siyan Zhan,Susanna C. Larsson,Yao Xie,Yuan Ding,Xue Li,Christos Socrates Mantzoros
出处
期刊:Metabolism-clinical and Experimental [Elsevier BV]
卷期号:183: 156711-156711
标识
DOI:10.1016/j.metabol.2026.156711
摘要

BACKGROUND: The long-term health effects of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) remain unclear. Most importantly, it is highly controversial whether GIP agonists vs. antagonists should be developed and what their effects and/or potential side effects would be in the clinic. Further investigation is needed to explore the effects of GIP lowering alone or in combination with GLP-1 enhancing. Tree-structured phenotypic modeling (TreeWAS) and factorial Mendelian randomization (MR) analyses are valuable in this context, even though the highest circulating GLP-1 levels may reflect only a minimum activation i.e. levels achieved with pharmacological intervention with dipeptidyl peptidase 4 (DPP-4) inhibitors and not GLP-1 receptor agonists (GLP-1 RAs) which achieve much higher levels. METHODS: TreeWAS was first conducted to map associations of GLP-1 or GIP levels with a broad range of disease outcomes among 385,917 UK Biobank participants. Disease-trajectory analysis was applied to characterize temporal patterns of co-occurrence of multiple comorbidities related to GLP-1 or GIP or both. Subsequently, factorial MR was performed to investigate the joint effects of GLP-1 and GIP on the associated health outcomes. Finally, mediation analysis was employed to explore the underlying mechanisms through which GLP-1 and GIP exert their effects. RESULTS: TreeWAS analysis revealed associations of elevated genetically predicted GLP-1 levels, even within the normal range, with decreased risk of metabolic diseases (e.g. type 2 diabetes) and polyarthropathies (e.g. gout). While genetically determined low GIP levels were linked to reduced risk of obesity, metabolic diseases (e.g. disorders of lipoprotein metabolism and other lipidaemias), digestive/hepatic and cardiometabolic diseases. Consistently, disease-trajectory analysis identified four major comorbidity clusters among individuals with genetically proxied physiologically lower GLP-1 and higher GIP levels, primarily involving metabolic diseases (e.g. type 2 diabetes), musculoskeletal system diseases (e.g. gout), gastrointestinal and urinary system disorders. Furthermore, the combined exposure to genetically predicted higher GLP-1 and lower GIP levels were associated with complementary and additive reductions in the risk of obesity (HR = 0.93, 95%CI: 0.88-0.99, p = 0.018), CVD (HR = 0.97, 95%CI: 0.94-0.99, p = 0.021), venous thromboembolism (VTE) (HR = 0.91, 95%CI: 0.83-1.00, p = 0.039), and multiplicative effects on composite hepatic events (CHEs) (HR = 0.88, 95%CI: 0.77-0.99, p = 0.040). No side effects on bone metabolism were identified. Finally, mediation analysis revealed that genetically predicted lower physiological GIP levels were associated with lower risk of obesity, CVD, VTE, overall and cardiovascular-specific mortality, with body weight consistent with a potential mediating role in exploratory decomposition analyses. CONCLUSIONS: Our genetic findings are consistent with the hypothesis that GLP-1 levels in the higher physiological range and GIP levels in the lower physiological range, individually and jointly, may be associated with lower body weight and improved cardiometabolic and liver phenotypes, while these observations warrant mechanistic and clinical investigation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丘比特的应助被anan27采纳,获得30
刚刚
魔幻书瑶完成签到,获得积分10
刚刚
刚刚
Katze发布了新的文献求助10
刚刚
LLLL完成签到,获得积分10
刚刚
Zhaoyu完成签到,获得积分10
1秒前
SciGPT的应助被whatever采纳,获得50
1秒前
彩色的忆霜完成签到 ,获得积分10
1秒前
1秒前
小白兔完成签到,获得积分10
1秒前
二十八完成签到,获得积分10
2秒前
中和皇极的应助被hp571采纳,获得10
2秒前
路期完成签到,获得积分10
2秒前
maocai0306发布了新的文献求助10
3秒前
3秒前
小七2022完成签到,获得积分10
3秒前
小Q完成签到,获得积分10
3秒前
4秒前
feng完成签到,获得积分10
4秒前
4秒前
XJC完成签到,获得积分10
4秒前
kong完成签到,获得积分10
4秒前
4秒前
玉子烧完成签到,获得积分10
5秒前
5秒前
LZNUDT完成签到,获得积分20
5秒前
华年完成签到,获得积分10
5秒前
无语的听筠完成签到,获得积分10
5秒前
Slaimigo发布了新的文献求助10
6秒前
6秒前
jessie完成签到,获得积分10
6秒前
斯文败类的应助被Ice_zhao采纳,获得10
7秒前
积极的中蓝完成签到,获得积分10
7秒前
温暖的炒饭完成签到,获得积分10
7秒前
小可爱发布了新的文献求助10
7秒前
ef完成签到,获得积分10
7秒前
ty6789完成签到 ,获得积分10
7秒前
爱搞科研的壮壮完成签到 ,获得积分10
7秒前
SciGPT的应助被鲸luo采纳,获得10
8秒前
宋宋宋完成签到 ,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159581
求助须知:如何正确求助?哪些是违规求助? 9555100
关于积分的说明 21724719
捐赠科研通 7749543
什么是DOI,文献DOI怎么找? 3427281
关于科研通互助平台的介绍 2552278
邀请新用户注册赠送积分活动 2471619